Xvivo Perfusion AB (publ) (0RKL.L)
SEK 461.69
(1.25%)
SEK 461.69
(1.25%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 440.92 Million SEK | 29.37% |
| 2022 | 292.5 Million SEK | 41.29% |
| 2021 | 207.02 Million SEK | 23.75% |
| 2020 | 167.28 Million SEK | 5.32% |
| 2019 | 158.84 Million SEK | 29.7% |
| 2018 | 122.47 Million SEK | 15.43% |
| 2017 | 106.09 Million SEK | 7.27% |
| 2016 | 98.9 Million SEK | 28.73% |
| 2015 | 76.82 Million SEK | 34.87% |
| 2014 | 56.96 Million SEK | 29.85% |
| 2013 | 43.86 Million SEK | 290.88% |
| 2012 | 11.22 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 127.45 Million SEK | 2.12% |
| 2024 Q1 | 116.11 Million SEK | 2.63% |
| 2024 Q2 | 124.81 Million SEK | 7.5% |
| 2023 Q4 | 113.14 Million SEK | 10.6% |
| 2023 Q3 | 102.29 Million SEK | -8.39% |
| 2023 Q2 | 111.66 Million SEK | 19.28% |
| 2023 FY | 378.4 Million SEK | 29.37% |
| 2023 Q1 | 93.61 Million SEK | -0.95% |
| 2022 Q2 | 63.36 Million SEK | 4.57% |
| 2022 FY | 292.5 Million SEK | 41.29% |
| 2022 Q4 | 94.5 Million SEK | 27.66% |
| 2022 Q3 | 74.02 Million SEK | 16.82% |
| 2022 Q1 | 60.59 Million SEK | -15.44% |
| 2021 Q4 | 71.66 Million SEK | 70.76% |
| 2021 FY | 207.02 Million SEK | 23.75% |
| 2021 Q3 | 41.96 Million SEK | -22.14% |
| 2021 Q2 | 53.89 Million SEK | 36.46% |
| 2021 Q1 | 39.49 Million SEK | -10.89% |
| 2020 FY | 167.28 Million SEK | 5.32% |
| 2020 Q4 | 44.32 Million SEK | -14.43% |
| 2020 Q3 | 51.79 Million SEK | 65.41% |
| 2020 Q2 | 31.31 Million SEK | -11.44% |
| 2020 Q1 | 35.35 Million SEK | -19.78% |
| 2019 Q2 | 39.71 Million SEK | 2.43% |
| 2019 Q3 | 36.26 Million SEK | -8.69% |
| 2019 Q4 | 44.07 Million SEK | 21.54% |
| 2019 FY | 158.84 Million SEK | 29.7% |
| 2019 Q1 | 38.77 Million SEK | 7.18% |
| 2018 FY | 122.47 Million SEK | 15.43% |
| 2018 Q4 | 36.18 Million SEK | 19.41% |
| 2018 Q3 | 30.3 Million SEK | 4.37% |
| 2018 Q2 | 29.03 Million SEK | 7.67% |
| 2018 Q1 | 26.96 Million SEK | 0.22% |
| 2017 Q1 | 27.07 Million SEK | -4.21% |
| 2017 Q2 | 27.24 Million SEK | 0.63% |
| 2017 Q4 | 26.9 Million SEK | 8.18% |
| 2017 FY | 106.09 Million SEK | 7.27% |
| 2017 Q3 | 24.87 Million SEK | -8.72% |
| 2016 Q2 | 23.19 Million SEK | 3.2% |
| 2016 Q3 | 24.96 Million SEK | 7.64% |
| 2016 Q4 | 28.26 Million SEK | 13.2% |
| 2016 FY | 98.9 Million SEK | 28.73% |
| 2016 Q1 | 22.47 Million SEK | 16.39% |
| 2015 Q2 | 20.23 Million SEK | 3.59% |
| 2015 Q4 | 19.31 Million SEK | 8.76% |
| 2015 Q3 | 17.75 Million SEK | -12.24% |
| 2015 Q1 | 19.53 Million SEK | 3.25% |
| 2015 FY | 76.82 Million SEK | 34.87% |
| 2014 Q1 | 11.13 Million SEK | -15.12% |
| 2014 FY | 56.96 Million SEK | 29.85% |
| 2014 Q2 | 13.22 Million SEK | 18.72% |
| 2014 Q3 | 13.69 Million SEK | 3.53% |
| 2014 Q4 | 18.91 Million SEK | 38.17% |
| 2013 Q2 | 10.44 Million SEK | 8.63% |
| 2013 Q3 | 10.68 Million SEK | 2.26% |
| 2013 FY | 43.86 Million SEK | 290.88% |
| 2013 Q4 | 13.12 Million SEK | 22.83% |
| 2013 Q1 | 9.61 Million SEK | -14.31% |
| 2012 Q4 | 11.22 Million SEK | 0.0% |
| 2012 FY | 11.22 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|